Year archive

WPD Pharmaceuticals Inc. — 2024 filings

All 43 regulatory filings released by WPD Pharmaceuticals Inc. (WBIO) in 2024, sourced directly from the official regulator.

43 Filings

2024 Period

2024 filings (43)

Filing	Released	Lang
News release - English.pdf Share Issue/Capital Change	2024-12-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-12-12	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-12-12	English
Interim MD&A - English.pdf Management Reports	2024-12-12	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2024	2024-12-12	English
News release - English.pdf Share Issue/Capital Change	2024-12-04	English
Material change report - English.pdf Regulatory Filings	2024-09-20	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2024-08-02	English
Material change report - English.pdf Regulatory Filings	2024-08-02	English
News release - English.pdf Regulatory Filings	2024-07-25	English
Notice of the meeting and record date (amended) - English.pdf Regulatory Filings	2024-06-27	English
Material change report - English.pdf Regulatory Filings	2024-06-12	English
News release - English.pdf Regulatory Filings	2024-06-06	English
Material change report - English.pdf Regulatory Filings	2024-06-03	English
Material change report - English.pdf Regulatory Filings	2024-05-16	English
News release - English.pdf Regulatory Filings	2024-05-16	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-05-08	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-05-08	English
Annual MD&A - English.pdf Regulatory Filings	2024-05-08	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-05-08	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-05-08	English
Audited annual financial statements – English.pdf Regulatory Filings	2024-05-08	English
Material change report - English.pdf Regulatory Filings	2024-02-07	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-05	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-02-05	English
Interim MD&A - English.pdf Regulatory Filings	2024-02-05	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-02	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-02-02	English
Interim MD&A - English.pdf Regulatory Filings	2024-02-02	English
Interim MD&A - English.pdf Regulatory Filings	2024-02-02	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-02-02	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-01-26	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-01-26	English
Annual MD&A - English.pdf Regulatory Filings	2024-01-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-26	English
Audited annual financial statements – English.pdf Regulatory Filings	2024-01-26	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-01-26	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-01-26	English
Annual MD&A - English.pdf Regulatory Filings	2024-01-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-26	English
News release - English.pdf Regulatory Filings	2024-01-04	English